Bio-Rad Laboratories ROE 2006-2019 | BIO

Current and historical return on equity (ROE) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Bio-Rad Laboratories ROE for the three months ending March 31, 2019 was 4.15%.
Bio-Rad Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.57B $4.86B 12.44%
2018-12-31 $0.37B $4.02B 8.09%
2018-09-30 $1.28B $4.90B 30.12%
2018-06-30 $1.03B $4.64B 27.64%
2018-03-31 $0.77B $4.49B 23.46%
2017-12-31 $0.12B $2.93B 4.32%
2017-09-30 $0.02B $2.85B 0.58%
2017-06-30 $0.01B $2.81B 0.44%
2017-03-31 $0.03B $2.71B 0.94%
2016-12-31 $0.03B $2.58B 0.96%
2016-09-30 $0.09B $2.70B 3.63%
2016-06-30 $0.09B $2.62B 3.69%
2016-03-31 $0.10B $2.54B 4.19%
2015-12-31 $0.11B $2.49B 4.60%
2015-09-30 $0.10B $2.43B 4.45%
2015-06-30 $0.10B $2.36B 4.35%
2015-03-31 $0.10B $2.20B 4.59%
2014-12-31 $0.09B $2.19B 4.07%
2014-09-30 $0.08B $2.18B 3.66%
2014-06-30 $0.06B $2.25B 2.82%
2014-03-31 $0.07B $2.23B 3.02%
2013-12-31 $0.08B $2.19B 3.71%
2013-09-30 $0.09B $2.12B 4.42%
2013-06-30 $0.14B $2.07B 7.00%
2013-03-31 $0.15B $2.03B 7.86%
2012-12-31 $0.17B $2.02B 8.64%
2012-09-30 $0.18B $1.94B 9.88%
2012-06-30 $0.19B $1.85B 10.38%
2012-03-31 $0.18B $1.84B 10.11%
2011-12-31 $0.18B $1.74B 10.57%
2011-09-30 $0.19B $1.69B 11.38%
2011-06-30 $0.19B $1.73B 11.79%
2011-03-31 $0.18B $1.61B 12.51%
2010-12-31 $0.19B $1.54B 13.35%
2010-09-30 $0.16B $1.43B 11.75%
2010-06-30 $0.15B $1.30B 11.74%
2010-03-31 $0.15B $1.30B 12.16%
2009-12-31 $0.15B $1.28B 12.36%
2009-09-30 $0.10B $1.23B 8.83%
2009-06-30 $0.09B $1.13B 8.17%
2009-03-31 $0.09B $1.06B 8.66%
2008-12-31 $0.09B $1.07B 8.24%
2008-09-30 $0.11B $1.05B 10.33%
2008-06-30 $0.11B $1.12B 10.60%
2008-03-31 $0.09B $1.08B 9.44%
2007-12-31 $0.09B $0.97B 10.12%
2007-09-30 $0.10B $0.95B 11.12%
2007-06-30 $0.09B $0.90B 11.06%
2007-03-31 $0.10B $0.86B 12.29%
2006-12-31 $0.10B $0.82B 13.45%
2006-09-30 $0.10B $0.79B 13.65%
2006-06-30 $0.09B $0.76B 13.30%
2006-03-31 $0.08B $0.70B 11.82%
2005-12-31 $0.08B $0.66B 12.50%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.239B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Stryker (SYK) United States $78.520B 28.02
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
ResMed (RMD) United States $17.890B 34.18
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
ICU Medical (ICUI) United States $5.103B 30.45
GW Pharmaceuticals (GWPH) United Kingdom $5.007B 0.00
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Cardiovascular Systems (CSII) United States $1.549B 889.60
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
BioLife Solutions (BLFS) United States $0.319B 99.82
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00